Title: Correction to Exosomal <scp>circDNER</scp> enhances paclitaxel resistance and tumorigenicity of lung cancer via targeting <scp>miR</scp>‐139‐5p/<scp>ITGB8</scp>
Abstract: Thoracic CancerEarly View CORRECTIONOpen Access Correction to Exosomal circDNER enhances paclitaxel resistance and tumorigenicity of lung cancer via targeting miR-139-5p/ITGB8 This article corrects the following: Exosomal circDNER enhances paclitaxel resistance and tumorigenicity of lung cancer via targeting miR-139-5p/ITGB8 Jinyou Li, Tao Zhu, Yuan Weng, Fengyue Cheng, Qi Sun, Kejia Yang, Zhenyu Su, Haitao Ma, Volume 13Issue 9Thoracic Cancer pages: 1381-1390 First Published online: April 9, 2022 First published: 22 March 2023 https://doi.org/10.1111/1759-7714.14857AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL In Jinyou Li et al.1 the following errors were published on page 1384. The exosome identification result of A549 cell line in Figure 2a was misused which was the 80 000x result of A549/PTX cell line (Figure B). The correct one should be the A549 cell line 100 000x exosome identification result (Figure A). FIGURE A Correct A549 cell line exosome electron microscope result(100 000x). FIGURE B The article is now regarded as the electron microscopy results of the A549/PTX cell line misused by A549(80 000x). FIGURE C Electron microscopy results of the A549/PTX cell line correctly used in the current article(100 000x). The authors apologize for the errors and any inconvenience they may have caused. REFERENCE 1Li J, Zhu T, Weng Y, Cheng F, Sun Q, Yang K, et al. Exosomal circDNER enhances paclitaxel resistance and tumorigenicity of lung cancer via targeting miR-139-5p/ITGB8. Thorac Cancer. 2022; 13: 1381– 90. https://doi.org/10.1111/1759-7714.14402 Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation